UCL Business Ltd(@UCL_Business ):What a year 2024 has been for Trace Neuroscience, with one of the largest biopharma Series A rounds in recent years funding the development of a treatment for amyotrophic lateral sclerosis (ALS), which affects 5000 people in the UK. UCLB played a crucial role in supporting the intellectual property behind the discovery and facilitating the collaboration between Trace Neuroscience and the academic team at @ucl. Find out more here:

UCL Business Ltd

@UCL_Business

UCL Business Ltd (UCLB) is the technology commercialisation company of @ucl | @ucltf fund for UCL academics | member of TenU @TenU_News

Joined July 2012

609 Following 1.6K Followers

UCL Business Ltd@UCL_Business

2024.12.17 16:58

What a year 2024 has been for Trace Neuroscience, with one of the largest biopharma Series A rounds in recent years funding the development of a treatment for amyotrophic lateral sclerosis (ALS), which affects 5000 people in the UK. UCLB played a crucial role in supporting the intellectual property behind the discovery and facilitating the collaboration between Trace Neuroscience and the academic team at @ucl. Find out more here: https://t.co/bAQSoCghvl